XML 62 R39.htm IDEA: XBRL DOCUMENT v3.26.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule of loss before income taxes

For the years ended December 31, 2025 and 2024, the loss before income taxes consisted of the following (in thousands):

 

 

2025

 

 

2024

 

Domestic

 

$

(106,911

)

 

$

(86,185

)

Foreign

 

 

828

 

 

 

(622

)

Total

 

$

(106,083

)

 

$

(86,807

)

 

Schedule of Income Tax Provision

The Company's income tax provision, net consisted of the following (in thousands):

 

 

2025

 

 

2024

 

Components of income tax provision:

 

 

 

 

 

 

Current:

 

 

 

 

 

 

Federal

 

$

 

 

$

 

State

 

 

78

 

 

 

112

 

Foreign

 

 

30

 

 

 

 

Total Current

 

 

108

 

 

 

112

 

Deferred:

 

 

 

 

 

 

Federal

 

 

 

 

 

 

State

 

 

 

 

 

 

Foreign

 

 

 

 

 

 

Total Deferred

 

 

 

 

 

 

Total Income Tax Provision

 

$

108

 

 

$

112

 

 

Summary of Reconciliation of Federal Statutory Income Tax Rate to Company's Effective Tax Rate

A reconciliation of the federal statutory income tax rate to the Company’s effective tax rate as of December 31, 2025 and 2024 is as follows (in thousands):

 

 

2025

 

 

2024

 

Income tax provision at statutory rate

 

$

(22,278

)

 

21.0

%

 

$

(18,229

)

 

21.0

%

State and local taxes, net of federal benefit

 

 

78

 

 

(0.1

)%

 

 

112

 

 

(0.1

)%

Foreign tax effects

 

 

 

 

 

 

 

 

 

 

Other foreign jurisdictions

 

 

(144

)

 

0.1

%

 

 

131

 

 

(0.2

)%

Tax credits

 

 

 

 

 

 

 

 

 

 

Research and development credits

 

 

2,729

 

 

(2.5

)%

 

 

(3,088

)

 

3.6

%

Orphan drug credits

 

 

(20,441

)

 

19.3

%

 

 

 

 

%

Nontaxable or nondeductible items

 

 

1,786

 

 

(1.7

)%

 

 

1,184

 

 

(1.4

)%

Changes in valuation allowance

 

 

35,097

 

 

(33.1

)%

 

 

19,630

 

 

(22.6

)%

Other items

 

 

 

 

 

 

 

 

 

 

NOL adjustment - Section 382 study

 

 

3,157

 

 

(2.9

)%

 

 

 

 

%

Other

 

 

124

 

 

(0.1

)%

 

 

372

 

 

(0.3

)%

Total

 

$

108

 

 

(0.0

)%

 

$

112

 

 

0.0

%

Summary of Deferred Tax Assets (Liabilities)

Temporary differences that give rise to significant deferred tax assets (liabilities) as of December 31, 2025 and 2024 are as follows (in thousands):

 

 

2025

 

 

2024

 

Deferred tax assets:

 

 

 

 

 

 

Net operating loss carryforwards

 

$

84,238

 

 

$

55,826

 

Stock-based compensation expense

 

 

3,009

 

 

 

2,450

 

Capitalized research and development expenses

 

 

24,440

 

 

 

32,422

 

Tax credit carryforwards

 

 

31,980

 

 

 

13,582

 

Accrued expenses and other current liabilities

 

 

1,368

 

 

 

1,025

 

Lease liability

 

 

4,520

 

 

 

4,903

 

Other

 

 

993

 

 

 

938

 

Total deferred tax assets

 

 

150,548

 

 

 

111,146

 

Deferred tax liabilities:

 

 

 

 

 

 

Right-of-use assets

 

 

(4,117

)

 

 

(4,540

)

Depreciable assets

 

 

(266

)

 

 

(312

)

Prepaid expenses and other current assets

 

 

(433

)

 

 

(443

)

Valuation allowance

 

 

(145,732

)

 

 

(105,851

)

Net deferred tax assets

 

$

 

 

$